Amyloid-beta proteins of Alzheimer’s disease are found to be the deciding factor for the survival of the deadliest form of skin cancer cells after their spread in the brain.
New Link Between Alzheimer�s Disease and Severe COVID-19 Infection
A new study suggests that genetic variant of Alzheimer’s disease may increase COVID-19 related brain damage.
A new study suggests that genetic variant of Alzheimer’s disease may increase COVID-19 related brain damage.
‘Amyloid-beta proteins of Alzheimer’s disease are found to be the deciding factor for the survival of the deadliest form of skin cancer cells — melanoma after their spread in the brain.
’
The study revealed that metastatic melanoma cells recovered from human brains and grown in tissue cultures make roughly three times as much amyloid-beta as cancer cells that have spread to other parts of the body. “Our study reveals an unexpected role for tumor-secreted amyloid beta in promoting the survival of melanoma brain metastases, and suggest a new way to counter it,” says senior study author Eva Hernando, PhD, professor in the Department of Pathology, and assistant dean for Research Integration, at NYU Langone Health.
Source-Medindia
COVID-19 may Cause More Neurological Damage Than Alzheimer�s Disease
COVID-19 patients were found to have higher levels of blood markers of neurological damage over the short term when compared to patients with Alzheimer’s disease.
COVID-19 patients were found to have higher levels of blood markers of neurological damage over the short term when compared to patients with Alzheimer’s disease.
Cognitive Decline Not Always a Sign of Alzheimer�s Disease: Study
Cognitive trouble is not always the sign of Alzheimer's disease but can be part of the spectrum of normality in older age.
Cognitive trouble is not always the sign of Alzheimer's disease but can be part of the spectrum of normality in older age.
